These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28646284)

  • 1. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
    Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
    Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
    PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
    Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
    J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
    Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
    Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
    Liu W; Xu J; Zhang C
    Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2.
    He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF
    Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
    Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
    Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis.
    Zhang L; Jiang Y; Jiao P; Deng X; Xie Y
    Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
    Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
    J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
    Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHD1L: a novel oncogene.
    Cheng W; Su Y; Xu F
    Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD1L is a novel independent prognostic factor for gastric cancer.
    Su Z; Zhao J; Xian G; Geng W; Rong Z; Wu Y; Qin C
    Clin Transl Oncol; 2014 Aug; 16(8):702-7. PubMed ID: 24258459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
    Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
    Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
    Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells.
    Xu X; He Y; Miao X; Wu Y; Han J; Wang Q; Liu J; Zhong F; Ou Y; Wang Y; He S
    Leuk Res; 2016 Aug; 47():54-62. PubMed ID: 27258734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
    Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
    Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.